Registry for Cryoablation Procedures in Children
Infant and Child European Cryoablation Project ICECaP
This study is collecting information on how well cryoablation works and its safety for children who need this treatment for soft tissue or bone issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Great Ormond Street Hospital for Children NHS Foundation Trust Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT03721783 on ClinicalTrials.gov |
What this trial studies
This registry aims to audit the applications, success rates, safety profiles, complication rates, and efficacy of cryoablation procedures performed on pediatric patients. Cryoablation is a minimally invasive technique that uses extreme cold to destroy soft tissue or bone lesions, offering advantages such as faster recovery and reduced complications compared to traditional surgery. The study will include all children who are treated with percutaneous cryoablation, regardless of whether the procedure was technically feasible. The goal is to gather comprehensive data to better understand the use of cryoablation in a pediatric population.
Who should consider this trial
Good fit: Ideal candidates for this registry are children who are being considered for treatment with percutaneous cryoablation.
Not a fit: Patients who are not undergoing cryoablation or have conditions that are not suitable for this treatment may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding and application of cryoablation in children, leading to improved treatment outcomes.
How similar studies have performed: While cryoablation is well-established in adult populations, its application in children is novel and underreported, indicating that this registry could provide valuable new insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all children in whom a clinical decision is made to treat with percutaneous cryoablation, to include those in whom cryoablation was not technically or clinically possible at any stage. Exclusion Criteria: * none
Where this trial is running
London
- Great — London, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Alex Barnacle, BM — Great Ormond Street Hospital, London, UK
- Study coordinator: Alex Barnacle, BM
- Email: Alex.Barnacle@gosh.nhs.uk
- Phone: +447810792517
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.